Modified risk stratification grouping using standard clinical and biopsy information for patients undergoing radical prostatectomy: Results from SEARCH.

Zachary S ZumstegZinan ChenLauren E HowardChristopher L AmlingWilliam J AronsonMatthew R CooperbergChristopher J KaneMartha K TerrisDaniel E SprattHoward M SandlerStephen J Freedland

Published in: The Prostate (2017)

Patients classified as VHR have markedly increased rates of PSA relapse, DM, and PCSM in comparison to SHR patients, whereas UIR and SHR patients have similar prognosis. Novel therapeutic strategies are needed for patients with VHR, likely involving multimodality therapy.

Keyphrases

end stage renal disease
prostate cancer
radical prostatectomy
ejection fraction
newly diagnosed
chronic kidney disease
patients undergoing
peritoneal dialysis
prognostic factors
stem cells
type diabetes
patient reported outcomes
adipose tissue
bone marrow